
Explore our educational resources about loss of smell and the role of type 2 inflammation in CRSwNP, featuring expert insights from Profs. Wytske Fokkens and Joaquim Mullol.
Learn about the multifaceted burden of uncontrolled pediatric asthma on patients and their caregivers.

Join Dr. Hanania to understand how to identify patients at risk of fixed airway obstruction in clinical settings.

Dr. Stephanie Christenson discusses the association between COPD exacerbations and the increased risks of morbidity and mortality
An infographic exploring the pathophysiology of prurigo nodularis and the role of type 2 inflammation.

An interactive tool used to explore the global burden of atopic dermatitis in children and adolescents.
In this video soundbite from the ERS-ISIAN 2025 symposium, Dr. Vibeke Backer discusses how Type 2 inflammation drives severe, uncontrolled CRSwNP. It covers key immune cells and biomarkers (e.g., IL-4, IL-5, IL-13, TSLP), global prevalence differences, and the importance of symptom tracking and targeted therapies.
Dr. Evan Dellon highlights how resolution of food impaction can be leveraged as an opportunity to diagnose EoE.
Learn from Prof. Seema Aceves about the interconnectivity of type 2 inflammation and barrier dysfunction in mediating EoE pathophysiology.

Dr. Simpson explores the concept of remission in AD, focusing on minimal disease activity and long-term remission, discussing how disease modification in AD can impact the course of the disease and its associated comorbidities.
Hear from Prof. Papadopoulou as she discusses how EoE can impact different aspects of disease burden in pediatric patients and their caregivers.